Elevated plasma adrenomedullin level in hyperthryoidism

European Journal of Clinical Investigation

Volumn 26, Issue 6, 1996, Pages 454-456

  Taniyama, M ^a,c   Kitamura, K ^b   Ban, Y ^a   Eto, T ^b   Katagiri, T ^a  

^a SHOWA UNIVERSITY   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

^c SHOWA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Adrenomedullin; Hyperthyroidism; Vasodilatation

Indexed keywords

ADRENOMEDULLIN; ANTITHYROID AGENT; THYROID HORMONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; MALE; PLASMA; PRIORITY JOURNAL; SERUM; THYROTOXICOSIS; VASODILATATION;

EID: 0029989695     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1996.155307.x     Document Type: Article

References (16)

1. Kitamura K, Kangawa K, Kawamoto M et al. Adrenomedullin: A novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1943;192:553-60.
2. Kitamura K, Sakata J, Kangawa K, Kojima M, Matsuo H, Eto T. Cloning and characterization oF cDNA encoding a precursor for human adrenomedullin. Biochem Biophys Res Commun 1993;194:720-5.
3. Ichiyama Y, Kitamura K, Ichiki Y et al. Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin, in rats. Eur J Pharmacol 1993;241:271-3.
4. Nuki C, Kawasaki H, Kitamura K et al. Vasodilator effect of adrenomedullin and calcitonin gene-related peptide receptors in rat mesenteric vascular beds. Biochem Biophys Res Commun 1993;196:245-51.
5. Ichiki Y, Kitamura K, Kangawu K, Kawamoto M, Matsuo H, Eto T. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FFBS Lett 1994;338:6-10.
6. Kitamura K, Ichiki Y, Tanaka M et al. Immunoreactive adrenomedullin in human plasma. FFBS Lett 1994;341:288-90.
7. Ishimitsu T, Nishikimi T, Saito Y et al. Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J Clin Invest 1994;94:2158-61.
8. Jougasaki M, Wei CM, McKinley LJ, Burnelt Jr JC. Elevation of circulating and ventricular adrenomedullin in human congestive heart failure. Circulation 1995;92:286-9.
9. Klein I. Thyroid hormone and the cardiovascular system. Am J Med 1990;88:631-7.
10. Woeber KA. Thyrotoxicosis and the heart. N Engl J Med 1992;327:94-8.
11. Theilen EO, Wilson WR. Hemodynamic effects of peripheral vasoconstriction in normal and thyrotoxic subjects. J Appl Physiol 1967;22:207-10.
12. Brent GA. The molecular basis of thyroid hormone action. N Engl J Med 1994;331:847-53.
13. Refetoff S. Thyroid function tests. In: DeGroot LJ, ed. Textbook of Endocrinology. Philadelphia: Saunders, 1995:617-64.
14. Sugo S, Minamino M, Kangawa K et al. Endothelial cells actively synthesize and secrete adrenomedullin. Biochem Biophys Res Commun 1994;201:1160-6.
15. Maughan WL, Sunagawa K, Burkhoff D et al. Effect of heart rate on the canine end-systolic pressure volume relationship. Circulation 1985;72:654-9.
16. Klein I. Thyroid hormone and blood pressure regulation. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis and Management. New York: Raven Press, 1990;1661-74.